• 

  Pfizer Covid vaccine induces 'good' immune response against coronavirus variants

  World | July 05, 2021 15:53 IST

  The research, published in the journal Nature Communications on June 28, found that the immune response was as strong against the Alpha variant first identified in the UK, as against the original virus found in Wuhan, China in 2019.

• 

  AstraZeneca shot followed by Pfizer showed higher antibodies: Study

  World | June 29, 2021 23:04 IST

  The Com-Cov trial, led by researchers from the University of Oxford, looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other.

• 

  COVID: Indonesia examines use of Sinovac, Pfizer vaccines for kids

  World | June 26, 2021 14:58 IST

  China has approved the emergency use of its Sinovac vaccine for children as young as three-year-old, while the US has green-lighted the Pfizer jab for those as young as 12, reports Xinhua news agency.

• 

  One shot of Pfizer, AstraZeneca vax offers 60% protection against COVID-19 pandemic

  World | June 24, 2021 14:41 IST

  The study, led by researchers from the University College London, in the UK showed that the protective effect of a single dose of vaccination is evident from 4 weeks to at least 7 weeks after vaccination.

• 

  Pfizer vaccine in final stages to get approval in India: CEO Albert Bourla

  India | June 22, 2021 19:04 IST

  As the Covid vaccination drive is underway in the country, Pfizer CEO Albert Bourla on Tuesday said that its vaccine is in the final stages to get approval in India.

• 

  Biden administration to share 1.60 crore Covid vaccine doses with India, other Asian countries

  World | June 22, 2021 8:29 IST

  The United States has announced a plan to share 55 million of the 80 million Covid-19 vaccine doses promised to the world by President Joe Biden.

• 

  Pfizer, Moderna Covid-19 vaccines don’t lower sperm count, study says

  World | June 19, 2021 9:59 IST

  The study, published on Thursday in the journal JAMA, recruited 45 healthy male volunteers aged 18 to 50 years scheduled for mRNA COVID-19 vaccination by Pfizer-BioNTech and Moderna.

• 

  Pfizer, AstraZeneca vaccines protect against Delta variant: Lancet study

  World | June 15, 2021 13:52 IST

  Pfizer and AstraZeneca vaccines provide good protection against Delta variant, says a study published in The Lancet journal.

• 

  Pfizer Covid-19 jabs protective against Beta, Gamma variant

  World | June 11, 2021 16:38 IST

  US pharmaceutical Pfizer's vaccine against Covid-19 can effectively neutralise Beta, Gamma variant of the Coronavirus disease, according to a study.

• 

  Jeetega India | Covid vaccine booster shots needed but timeline uncertain

  News | June 10, 2021 20:40 IST

  People who have been vaccinated against the coronavirus will require a booster shot to remain protected, according to the US’ top infectious disease expert Dr Anthony Fauci.

• 

  US to buy 500M Pfizer vaccines to share globally

  World | June 10, 2021 7:46 IST

  President Joe Biden was set to make the announcement Thursday in a speech before the start of the Group of Seven summit.

Advertisement
• 

  Talks with Pfizer, Moderna for Covid vaccines under consideration, No conclusion yet: Dr VK Paul

  India | June 09, 2021 10:42 IST

  The Pfizer vaccine, which is manufactured in collaboration with German Biotechnology firm BioNTech, is the only vaccine currently being administered to children in a few countries.

• 

  Pfizer expands vaccine tests in kids under 12

  World | June 08, 2021 23:22 IST

  Pfizer says it is expanding testing of its COVID-19 vaccine in children younger than 12. After a first-step study in a small number of young children to test different doses, Pfizer is ready to enroll about 4,500 young volunteers at more than 90 sites in the U.S., Finland, Poland and Spain.  

• 

  Pfizer, Moderna vaccines can reduce COVID risk by 91 per cent: US CDC

  World | June 08, 2021 12:18 IST

  Even a single dose of the mRNA vaccines can reduce the risk of infection by 81 per cent. These estimates included symptomatic and asymptomatic infections.

• 

  UK Approves Pfizer-BioNTech Covid-19 Vaccine For Children Between 12 To 15-Year-Olds

  News | June 05, 2021 8:20 IST

  In a significant step amid the ongoing battle against Covid-19, the Britain's medicines regulator has appoved Pfizer/BioNTech vaccine for for adolescents aged 12 to 15 after a "rigorous review".

• 

  Quickly deliver second doses, provide boosters for Delta variant: Lancet

  India | June 04, 2021 23:17 IST

  For the 'Delta variant' of the coronavirus, there needs to be shorter gap between two doses of anti-Covid vaccines, says a Lancet study, as the contagious virus continues to evolve, infect people.

• 

  Jeetega India | Pfizer vaccine approved for 12-15 year olds by UK regulator

  News | June 04, 2021 20:22 IST

  Pfizer-BioNTech vaccine against coronavirus has been approved by UK regulator for 12 to 15-year-old children, AFP reported on Friday. Last week, the European Medicines Agency recommended that the use of the coronavirus vaccine made by Pfizer and BioNTech be expanded to children ages 12 to 15, a decision that offers younger and less at-risk populations across the continent access to a COVID-19 shot for the first time.

• 

  Pfizer vaccine approved for children in age group 12 to 15: UK Regulator

  World | June 04, 2021 16:17 IST

  Pfizer-BioNTech vaccine against coronavirus has been approved by UK regulator for 12 to 15-year-old children, AFP reported on Friday.

• 

  63% adults have received at least one Covid-19 vaccine dose: Joe Biden

  World | June 04, 2021 9:05 IST

  US will donate 75 per cent of its unused Covid-19 vaccine stockpile to the United Nations-led COVAX global vaccine program which has delivered less than 80 million doses so far.

• 

  No clinical trials required in India for global Covid vaccines: DCGI

  India | June 02, 2021 17:33 IST

  Globally available Covid 19 vaccines can now be launched in India without the requirement of post approval clinical trials and testing every batch of the vaccine.